Phase I trial of irofulven (MG 114) in pediatric patients with solid tumors - Bomgaars,L.R.; Megason,G.C.; Pullen,J.; Langevin,A.M.; Weitman,S.D.; Hershon,L. (Pediatr Blood Cancer, 2006)